NEUP

2.3501.29%
TM

Timothy M. Cunningham

Interim CFO & Principal Accounting Officer

Mr. Timothy M. Cunningham, also known as Tim, MBA, CPA, was Chief Financial Officer at Neuphoria Therapeutics Inc. (formerly known as Bionomics Limited) since July 01, 2023 until 2026 and serves as its Fractional CFO since 2026. Mr. Cunningham is Interim CFO & Principal Accounting Officer of Rein Therapeutics Inc. (formerly known as Aileron Therapeutics, Inc.) from May 16, 2024. He served as Acting Chief Financial Officer for SAB Biotherapeutics, Inc. from October 2020 to December 2021. He has been Director at ChitogenX Inc. (formerly known as Ortho Regenerative Technologies Inc.) since June 14, 2021. He served as Acting Chief Financial Officer at Peak Bio, Inc. since November 01, 2022 and served as its Interim Chief Financial Officer. Mr. Cunningham served as Interim Chief Financial Officer and Principal Financial Officer at Alaunos Therapeutics, Inc. (formerly known as ZIOPHARM Oncology, Inc.) since February 17, 2021. He was Chief Financial Officer at Organogenesis Holdings Inc. since September 19, 2016 until August 18, 2020. Mr. Cunningham serves as the Chief Financial Officer at Vestigo Ventures LLC. He served as the Chief Financial Officer and Senior Vice President at DialogTech, Inc. since 2014 until December 25, 2015. He has served as a Chief Financial Officer Consultant at Danforth. He has been employed by Danforth Advisors, LLC since September 2020. Mr. Cunningham Co-Founded Metatomix Corporation in 2000 and served as its Chief Financial Officer, Executive Vice President of Finance and Administration. Previously, Mr. Cunningham served as an Interim Chief Executive Officer at Metatomix Corporation and played an integral role in building Metatomix infrastructure, raising money and completing acquisitions and managing the financial side of the business. Prior Ifbyphone, Mr. Cunningham was a Senior Financial Executive and Chief Financial Officer at five different software companies. He has led three companies through the IPO process, including two sold on the verge of IPO. These organizations ranged from Infinium Software to his previous company GFI Software. Prior thereto, he served as a Chief Financial Officer and Executive Vice President of Finance and Administration at MediaBridge Technologies, Inc. He served for Infinium Software, Inc., where he built a financial management infrastructure that enabled it to go public. He also served positions at PriceWaterhouseCoopers LLP and KPMG. He served as a Director of Metatomix Corporation. Mr. Cunningham has many years of financial tech experience. He is a trusted advisor and subject matter expert in strategic planning and creative, scalable, business design and has a proven track record of driving growth leading to either a successful exit via sale or IPO. He holds a Bachelors of Science degree in Accounting from the Carroll School of Management at Boston College, an MBA in Finance from the Boston University and a CPA (Certified Public Accountant) designation from the State of New York.

Positions